Add BrightSurf on Google Email

Tumor avatars to fight colorectal cancer

A UNIGE team created customizable treatments by testing drugs on artificial tumors derived from patients' cancer tissue. The approach opens the way for optimized and tailored therapies against various cancers and diseases.

SourceUniversité de Genève·JournalJournal of Experimental & Clinical Cancer Research·TypeNews article·DateApr 4, 2023

Forsyth microbiologists discover a regulatory mechanism that keeps cancer-causing bacteria in check

Researchers at the Forsyth Institute have discovered a molecule naturally produced by the human host that targets and inhibits Fusobacteria, an opportunistic oral pathogen linked to colorectal cancer. The findings suggest a chemically modified version of this molecule could be used as a potential therapeutic to prevent colorectal cance...

SourceForsyth Institute·JournalThe ISME Journal·TypeExperimental study·DateApr 4, 2023

LSU Health New Orleans LA Tumor Registry releases 6th Census Tract Cancer Incidence Report

The LSU Health New Orleans Louisiana Tumor Registry released the sixth report of statewide cancer incidence rates by census tract, finding that 81% of tracts met criteria for all cancers combined. Census tracts with statistically higher incidence rates were found in parishes including Orleans, Lafourche, and St. Bernard.

SourceLouisiana State University Health Sciences Center·TypeData/statistical analysis·DateApr 3, 2023

Study shows physical activity prevents, not just delays, cancer recurrence in patients previously treated for colon cancer

Researchers found that physical activity can prevent cancer recurrence in stage III colon cancer patients by lowering the recurrence rate within the first year of treatment. This association persisted for approximately three years after surgery, suggesting a long-term survival benefit.

SourcePennington Biomedical Research Center·JournalBritish Journal of Sports Medicine·TypeRandomized controlled/clinical trial·DateMar 21, 2023

Death rates from lung cancer will fall overall in the EU and UK in 2023, but rise among women in France, Italy and Spain

Lung cancer death rates are projected to decrease overall in the EU and UK in 2023, however, a concerning trend is observed among women in France, Italy, and Spain. Meanwhile, pancreatic cancer death rates are forecasted to rise among women due to continued smoking habits.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·TypeObservational study·DateMar 5, 2023

Study: More paid sick leave results in more cancer screenings

A Tulane University study found that areas with paid sick leave mandates experienced significant increases in breast cancer (4%) and colorectal cancer (6-8%) screenings among private sector employees. The findings suggest that non-monetary barriers to healthcare access can have a meaningful impact on health outcomes.

SourceTulane University·JournalNew England Journal of Medicine·TypeData/statistical analysis·DateMar 1, 2023

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

A study published in Nature Communications reveals that platinum accumulates in healthy cells surrounding cancer cells, particularly fibroblasts, and induces gene activation associated with poor response to chemotherapy. Periostin levels serve as a marker of TGF-β activity in fibroblasts and predict treatment benefit.

Swapping meat for Quorn’s mycoprotein may protect against bowel cancer, says study

Replacing red and processed meat with Quorn's mycoprotein reduces intestinal genotoxins, a risk factor for bowel cancer, and increases beneficial gut bacteria. The study found significant reductions in harmful chemicals and improvements in gut health in participants consuming the mycoprotein diet.

SourceNorthumbria University·JournalEuropean Journal of Nutrition·TypeRandomized controlled/clinical trial·DateFeb 16, 2023

The nutrient that cancer cells crave

Researchers found that arginine levels are limited in human cancers, prompting cancer cells to manipulate proteins to take up the amino acid. Starving cancer cells of arginine may lead to mutations that make them more recognizable to the immune system.

SourceRockefeller University·JournalScience Advances·DateFeb 3, 2023

Immunotherapy combined with targeted therapy for colorectal cancer yields promising outcomes for patients

A phase 2 clinical trial combining immunotherapy and targeted therapy showed a 24.3% confirmed response rate and 5-month median progression-free survival among patients with BRAF V600 mutations. The treatment also demonstrated increased durability, with 57% of patients remaining on treatment for more than 6 months.

SourceMassachusetts General Hospital·JournalNature Medicine·TypeExperimental study·DateJan 26, 2023

An unprecedented look at colorectal cancer

A team at Harvard Medical School has created large-scale 2D and 3D spatial maps of colorectal cancer, layering molecular information on top of histological features. The maps reveal the interconnectedness of traditional isolated structures in colorectal cancer, allowing researchers to explore differences within individual tumors.

SourceHarvard Medical School·JournalCell·DateJan 19, 2023

Surgery first for colon cancer? Not so fast, according to new study in JNCCN

Researchers discovered that pre-surgery immunotherapy significantly improved patient outcomes for locally advanced colorectal cancer. The treatment showed substantial longer survival benefits, including low recurrence rates, in patients with mismatch repair-deficient or microsatellite instability-high (dMMR/MSI-H) CRC.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateJan 11, 2023

Oncotarget | Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients

Researchers developed predictive models using serum microRNAs to identify patients at risk of requiring early palliative care. The study used serum samples from 178 patients with various types of cancer and found that miRNA-based models had higher accuracy than clinical models in predicting referral to a palliative care unit.

SourceImpact Journals LLC·JournalOncotarget·TypeObservational study·DateDec 29, 2022

Unlocking cancer’s ancestry

A new software developed by researchers at Cold Spring Harbor Laboratory can accurately infers continental ancestry from tumor DNA and RNA. This technology has the potential to lead to more targeted and personalized cancer treatments by identifying genetic connections between cancer and race or ethnicity.

SourceCold Spring Harbor Laboratory·JournalCancer Research·DateDec 27, 2022

AI improves colorectal cancer screening in Lynch syndrome

Researchers found that AI-assisted colonoscopy significantly improved adenoma detection rates in patients with Lynch syndrome, detecting flat adenomas more effectively than standard examinations. The study suggests that AI-assisted real-time colonoscopy is a promising approach to optimize endoscopic surveillance for LS patients.

SourceUniversitatsklinikum Bonn·JournalUnited European Gastroenterology Journal·DateDec 26, 2022

Large-scale study led by Fred Hutch finds new genetic risk factors for colorectal cancer, paving the way for better screening, prevention

A comprehensive analysis of over 100,000 colorectal cancer cases identified 100 new genetic risk factors strongly linked with the disease. These findings could help clinicians determine who's at highest risk for early detection and potentially identify candidates for preventive treatments.

SourceFred Hutchinson Cancer Center·JournalNature Genetics·TypeMeta-analysis·DateDec 20, 2022

Artificial Intelligence in Health: USC Researchers receive $10.5 million to develop cutting edge machine learning approaches in cancer research

The National Cancer Institute awards $10.5 million to USC's Division of Biostatistics to develop statistical methods for uncovering new risk factors associated with cancer by integrating large volumes of health, genomic, and exposure data. The project aims to provide new insights into complex biological processes and discoveries of nov...

New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

A new study found that a three-year interval between screenings using non-invasive multi-target stool DNA testing is clinically appropriate for individuals with average risk of colorectal cancer. The study, led by Thomas F. Imperiale, M.D., identified no colorectal cancers in participants after an initial negative test.

SourceRegenstrief Institute·JournalCancer Prevention Research·DateNov 29, 2022

Two new studies from Fred Hutchinson Cancer Center show how bacteria could help tumors progress and resist treatment

Researchers at the Fred Hutchinson Cancer Center discovered that oral bacteria like Fusobacterium nucleatum can infiltrate tumors, influencing their growth and response to treatment. The findings suggest a link between oral health and cancer, highlighting the potential for microbiome-based therapies to combat cancer.

SourceFred Hutchinson Cancer Center·JournalNature·TypeExperimental study·DateNov 16, 2022

Combined effect of bacteria and iron levels on the progression of colorectal cancer

Researchers found that excessive iron accumulation accelerates tumor growth in F. nucleatum-positive colorectal cancer by enhancing inflammatory responses in immune cells, promoting interpatient prognostic variability. Iron levels also modulate macrophage expression profiles, transforming them into pro-tumor cells expressing CCL8.

SourceKumamoto University·JournalJCI Insight·TypeExperimental study·DateNov 9, 2022

Tailored online personal health record cancer tool increases survivor adherence to national guidelines

A new online personal health record tool has significantly increased adherence by colorectal cancer survivors to national guidelines. The tool, developed by the Regenstrief Institute and other researchers, provides a patient-centered platform for tracking follow-up care, managing symptoms, and connecting with healthcare providers.

SourceRegenstrief Institute·JournalJMIR Cancer·DateNov 3, 2022

Overcoming resistance to colon cancer treatment

Researchers at UNIGE have discovered a way to overcome resistance to chemotherapy in colorectal cancer, using an optimized combination of tyrosine kinase inhibitors. This breakthrough opens up new avenues for developing targeted therapies that can effectively treat patients with low five-year survival rates.

SourceUniversité de Genève·JournalCancers·TypeNews article·DateOct 27, 2022

Study validates diagnostic assay for Asian cancers

A Singapore research team has validated a cancer diagnostic assay designed with Asian-centric biomarkers, showing high precision and sensitivity in measuring four major classes of biomarkers. The assay's performance was validated with clinical specimens, indicating its promise for reliable deployment in a clinical setting.

SourceSingHealth·JournalFrontiers in Molecular Biosciences·TypeRandomized controlled/clinical trial·DateOct 12, 2022

ACP says federal government needs to improve health support for indigenous communities

The American College of Physicians recommends increasing funding for health services and prioritizing health promotion in Indigenous communities. Community-driven public policy is also necessary to address historical trauma, social determinants of health, and inadequate access to healthcare services.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeObservational study·DateOct 10, 2022